Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial.

Published in: Journal of diabetes investigation (2024)

Either IF 16:8 or 14:10 had a benefit in the percentage weight change, glucose and lipid profiles in obese diabetic patients compared with the control group when consumed for 3 days a week for 3 months.

Keyphrases

weight loss
weight gain
metabolic syndrome
end stage renal disease
insulin resistance
type diabetes
body mass index
blood glucose
bariatric surgery
ejection fraction
newly diagnosed
physical activity
chronic kidney disease
prognostic factors
high intensity
body weight
clinical trial